Excelsior Biofilms LLC is a biotechnology firm specializing in the research, development, and testing of novel anti-biofilm technologies. Their solutions aim to improve antimicrobial efficacy for medical, industrial, and household use.
Excelsior Biofilms LLC is a biotechnology company focused on the development and research of novel anti-biofilm technologies. Founded by Ph.D. researchers with extensive experience in biofilm control, the firm creates antimicrobial solutions designed to enhance the efficiency of existing antimicrobials. Their technology platforms, which include proprietary biofilm dispersion inducers, are being developed for applications in medical, institutional, industrial, and household environments. The company also provides specialized testing services for proprietary and non-proprietary anti-biofilm technologies, operating out of the Binghamton University Innovative Technologies Complex in Vestal, New York.
The firm's primary product focus involves developing antimicrobial wound dressings, including adhesive bandages, to prevent, treat, and eliminate biofilm infections in topical wounds. By addressing the challenges of biofilm resistance, the company aims to provide solutions for healthcare providers, clinical institutions, and individual consumers for daily wound care. With a history of securing research funding, including from the NIH, the company has established a portfolio of patents and has contributed to research in various microbiological and antimicrobial scientific journals. Their work serves sectors ranging from healthcare facilities to industrial and consumer goods.